FDA Registered Kimchi-Derived Postbiotic Ingredient
The regulatory approval allows the ingredient, known as beLP1, to enter the U.S. market for health-related use.
Updated on Oct. 2, 2026 in Weight Loss
Live Poll
Do you trust the safety of newly registered health supplements based on kimchi-derived ingredients?
The FDA has officially registered a kimchi-derived postbiotic strain, beLP1, as a New Dietary Ingredient. This regulatory milestone paves the way for the ingredient's potential inclusion in health products sold throughout the United States.
Why it matters
This registration allows the manufacturer, Bereum Co., Ltd., to legally market the postbiotic strain and its associated health claims in the U.S. By formalizing this status with federal regulators, the company clears a major hurdle to bring its product to the American consumer market.
A 12-week, double-blind, placebo-controlled study of 140 adults with a BMI of 25 to 35 observed improvements in digestive and psychological health scores. Researchers tested a daily intake of over 30 billion cells of the beLP1 strain.
The players
Bereum Co., Ltd.
A biotechnology company specializing in the development and patenting of postbiotic strains.
U.S. Food and Drug Administration
The federal agency responsible for regulating food and dietary ingredient safety and market entry.
The details
Postbiotics are non-viable bacterial products or metabolic byproducts that provide health benefits to the host. In this trial, participants consumed a high-count daily dose of the kimchi-derived beLP1 strain. The study measured improvements in Gastrointestinal Symptom Rating Scale (GSRS) scores, Perceived Stress Scale (PSS) levels, and Dermatology Life Quality Index (DQLQ) scores compared to the placebo group.
Timeline
July 2026: Bereum registered an anti-stress and tension relief patent.
August 2026: Bereum registered an obesity improvement patent.
September 2026: The human clinical trial results for beLP1 were published.
Health Landscape
The registration of beLP1 represents a significant expansion of the postbiotics market, signaling a shift toward more clinically validated bacterial-derived products. This development follows a broader trend of companies seeking formal regulatory status to differentiate new microbial ingredients.
While this ingredient is now registered, it is not a substitute for standard medical weight management or treatment for stress. If you are considering adding new probiotic or postbiotic supplements to your routine, discuss these products with your doctor to ensure they are appropriate.
The takeaway
This new regulatory status marks a formal step toward the availability of kimchi-derived postbiotics in the United States. Readers interested in gut health or stress management should continue to consult with a primary care physician before incorporating new dietary ingredients into their regimens.
Further reading
Learn more about the science of supplements in the Weight Loss section.
Source note: This article includes information reported by Business Korea.
Live Poll
Do you trust the safety of newly registered health supplements based on kimchi-derived ingredients?
